Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-06

Clinical Trial Update: Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial protocol evaluating safe ketone thresholds to minimize ketosis in people with Type 1 diabetes treated with dapagliflozin; currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: St Vincent's Hospital Melbourne | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: NOT_YET_RECRUITING